Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

LC726a

Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing LC726
Unstained: $185.00 Add to Cart
H&E (LC726as*): $185.00 Add to Cart

Microarray Panel:Lung adenocarcinoma tissue microarray with squamous cell carcinoma, containing 27 cases of lung adenocarcinoma, 26 lung squamous cell carcinoma, 6 lung atypical carcinoid, 3 lung large cell carcinoma, 7 lung small cell carcinoma, plus 3 normal lung tissue, single core per case
Cores:72
Cases:72
Layout:9 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789 
A Lun Lun Lun Lun Lun Lun Lun Lun Lun  
B Lun Lun Lun Lun Lun Lun Lun Lun Lun  
C Lun Lun Lun Lun Lun Lun Lun Lun Lun  
D Lun Lun Lun Lun Lun Lun Lun Lun Lun  
E Lun Lun Lun Lun Lun Lun Lun Lun Lun  
F Lun Lun Lun Lun Lun Lun Lun Lun Lun  
G Lun Lun Lun Lun Lun Lun Lun Lun Lun  
H Lun Lun Lun Lun Lun Lun Lun Lun Lun Marked point
Legend: Lun - Lung

- Malignant tumor, - Malignant tumor (stage 1), - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage IIIa), - Malignant tumor (stage IIIb), - Malignant tumor (stage IV), - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 60 Lung Adenocarcinoma 1 IIIa T3N1M0 Malignant
A2 2 M 61 Lung Adenocarcinoma 1 II T2N1M0 Malignant
A3 3 M 47 Lung Adenocarcinoma 2 I T1N0M0 Malignant
A4 4 F 59 Lung Adenocarcinoma 2 II T2N1M0 Malignant
A5 5 M 62 Lung Adenocarcinoma 2 IV T2N1M1 Malignant
A6 6 F 61 Lung Adenocarcinoma 2 II T2N1M0 Malignant
A7 7 M 60 Lung Adenocarcinoma 2 IIIa T2N2M0 Malignant
A8 8 M 54 Lung Adenocarcinoma 2 I T2N0M0 Malignant
A9 9 F 49 Lung Adenocarcinoma 2 II T2N1M0 Malignant
B1 10 F 49 Lung Adenocarcinoma 3 II T2N1M0 Malignant
B2 11 M 75 Lung Adenocarcinoma 3 I T2N0M0 Malignant
B3 12 M 69 Lung Adenocarcinoma 3 I T2N0M0 Malignant
B4 13 M 59 Lung Adenocarcinoma 3 IIIa T3N1M0 Malignant
B5 14 F 67 Lung Adenocarcinoma 3 I T2N0M0 Malignant
B6 15 M 62 Lung Adenocarcinoma 3 IIIa T3N0M0 Malignant
B7 16 M 51 Lung Adenocarcinoma 3 II T2N1M0 Malignant
B8 17 F 36 Lung Adenocarcinoma 3 IIIa T2N2M0 Malignant
B9 18 M 69 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C1 19 F 46 Lung Adenocarcinoma 3 I T2N0M0 Malignant
C2 20 F 54 Lung Adenocarcinoma 3 IIIa T3N0M0 Malignant
C3 21 F 57 Lung Adenocarcinoma 2–3 IIIb T2N3M0 Malignant
C4 22 M 67 Lung Atypical carcinoid – I T2N0M0 Malignant
C5 23 M 72 Lung Atypical carcinoid – I T2N0M0 Malignant
C6 24 F 36 Lung Atypical carcinoid – I T2N0M0 Malignant
C7 25 M 49 Lung Atypical carcinoid – IIIb T4N2M0 Malignant
C8 26 M 60 Lung Atypical carcinoid – I T1N0M0 Malignant
C9 27 M 73 Lung Atypical carcinoid – IIIb T4N0M0 Malignant
D1 28 F 64 Lung Large cell carcinoma – IIIa T3N1M0 Malignant
D2 29 M 41 Lung Large cell carcinoma – IIIb T4N0M0 Malignant
D3 30 M 61 Lung Large cell carcinoma – IIIb T4N0M0 Malignant
D4 31 M 70 Lung Papillary adenocarcinoma 1 I T1N0M0 Malignant
D5 32 M 49 Lung Papillary adenocarcinoma 1 IIIb T4N0M0 Malignant
D6 33 M 46 Lung Papillary adenocarcinoma 1 I T2N0M0 Malignant
D7 34 M 60 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
D8 35 F 53 Lung Papillary adenocarcinoma 2 II T2N1M0 Malignant
D9 36 M 42 Lung Papillary adenocarcinoma 2 I T2N0M0 Malignant
E1 37 M 60 Lung Small cell carcinoma – I T2N0M0 Malignant
E2 38 F 63 Lung Small cell carcinoma – II T2N1M0 Malignant
E3 39 M 58 Lung Small cell carcinoma – II T2N1M0 Malignant
E4 40 M 60 Lung Small cell carcinoma – II T2N1M0 Malignant
E5 41 F 51 Lung Small cell carcinoma – I T1N0M0 Malignant
E6 42 M 54 Lung Small cell carcinoma – II T2N1M0 Malignant
E7 43 M 51 Lung Small cell carcinoma – IIIa T3N2M0 Malignant
E8 44 M 66 Lung Squamous cell carcinoma 1 I T2N0M0 Malignant
E9 45 M 57 Lung Squamous cell carcinoma 1 II T2N1M0 Malignant
F1 46 M 51 Lung Squamous cell carcinoma 1 I T2N0M0 Malignant
F2 47 M 68 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
F3 48 M 70 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
F4 49 M 55 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
F5 50 M 65 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
F6 51 M 50 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
F7 52 M 64 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
F8 53 M 66 Lung Squamous cell carcinoma 2 I T2N0M0 Malignant
F9 54 M 51 Lung Squamous cell carcinoma 2 II T2N1M0 Malignant
G1 55 M 46 Lung Squamous cell carcinoma 2 IIIa T2N2M0 Malignant
G2 56 M 58 Lung Squamous cell carcinoma 2 1 T2N0M0 Malignant
G3 57 M 68 Lung Squamous cell carcinoma 2 IIIb T4N0M0 Malignant
G4 58 M 72 Lung Squamous cell carcinoma 2 II T2N0M0 Malignant
G5 59 M 45 Lung Squamous cell carcinoma 3 II T2N1M0 Malignant
G6 60 M 55 Lung Squamous cell carcinoma 3 II T2N1M0 Malignant
G7 61 M 77 Lung Squamous cell carcinoma 3 IIIa T3N2M0 Malignant
G8 62 M 59 Lung Squamous cell carcinoma 3 II T2N0M0 Malignant
G9 63 M 64 Lung Squamous cell carcinoma 3 II T2N1M0 Malignant
H1 64 M 64 Lung Squamous cell carcinoma 3 IIIa T3N1M0 Malignant
H2 65 M 58 Lung Squamous cell carcinoma 3 II T2N0M0 Malignant
H3 66 F 35 Lung Squamous cell carcinoma 3 IIIb T4N1M0 Malignant
H4 67 M 67 Lung Squamous cell carcinoma 3 IIIa T3N0M0 Malignant
H5 68 F 51 Lung Squamous cell carcinoma 3 I T1N0M0 Malignant
H6 69 F 55 Lung Squamous cell carcinoma 3 II T2N1M0 Malignant
H7 70 M 24 Lung Normal lung tissue – – – Normal
H8 71 M 48 Lung Normal lung tissue – – – Normal
H9 72 M 47 Lung Normal lung tissue – – – Normal
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal